Back to Journals » OncoTargets and Therapy » Volume 14

Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib

Total article views   HTML views PDF downloads Totals
6,149 Dovepress* 5,424+ 700 6,124
PubMed Central* 725 238 963
Totals 6,149 938 7,087
*Since 25 March 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar